Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-1301-3p SFRP1 1.81 0 -4.58 0 MirTarget -0.63 0 NA
2 hsa-miR-16-1-3p SFRP1 1.3 0 -4.58 0 MirTarget -0.71 0 NA
3 hsa-miR-182-5p SFRP1 2.36 0 -4.58 0 mirMAP -0.97 0 NA
4 hsa-miR-429 SFRP1 2.84 0 -4.58 0 miRNATAP -0.48 0 NA
5 hsa-miR-484 SFRP1 0.35 0.00154 -4.58 0 MirTarget -0.74 0 NA
6 hsa-miR-625-5p SFRP1 0.73 0 -4.58 0 MirTarget -0.63 0 NA
7 hsa-miR-7-1-3p SFRP1 0.69 0 -4.58 0 MirTarget; mirMAP -0.63 0 NA
8 hsa-miR-96-5p SFRP1 3.25 0 -4.58 0 mirMAP -0.84 0 NA
NumGOOverlapSizeP ValueAdj. P Value
1 TISSUE DEVELOPMENT 56 1518 2.371e-30 1.103e-26
2 EMBRYO DEVELOPMENT 42 894 3.807e-26 8.856e-23
3 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 33 554 1.449e-23 2.248e-20
4 EPITHELIUM DEVELOPMENT 40 945 3.749e-23 4.362e-20
5 TISSUE MORPHOGENESIS 31 533 8.108e-22 7.545e-19
6 ORGAN MORPHOGENESIS 36 841 6.546e-21 5.077e-18
7 EMBRYONIC MORPHOGENESIS 30 539 1.435e-20 9.541e-18
8 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 47 1672 5.449e-20 3.169e-17
9 POSITIVE REGULATION OF GENE EXPRESSION 47 1733 2.347e-19 1.213e-16
10 SKELETAL SYSTEM DEVELOPMENT 27 455 3.049e-19 1.419e-16
11 PATTERN SPECIFICATION PROCESS 26 418 4.756e-19 2.012e-16
12 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 47 1805 1.217e-18 4.718e-16
13 WNT SIGNALING PATHWAY 24 351 1.443e-18 4.796e-16
14 REGIONALIZATION 23 311 1.413e-18 4.796e-16
15 GLAND DEVELOPMENT 25 395 1.632e-18 5.061e-16
16 CELL DEVELOPMENT 42 1426 1.947e-18 5.663e-16
17 MORPHOGENESIS OF AN EPITHELIUM 24 400 2.898e-17 7.491e-15
18 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 35 1021 2.868e-17 7.491e-15
19 TUBE DEVELOPMENT 27 552 4.088e-17 1.001e-14
20 NEUROGENESIS 40 1402 4.954e-17 1.152e-14
21 REGULATION OF CELL PROLIFERATION 41 1496 7.269e-17 1.611e-14
22 REGULATION OF CELL DIFFERENTIATION 40 1492 4.176e-16 8.832e-14
23 RESPONSE TO ORGANIC CYCLIC COMPOUND 32 917 5.406e-16 1.094e-13
24 GROWTH 23 410 6.171e-16 1.196e-13
25 RESPONSE TO ENDOGENOUS STIMULUS 39 1450 9.886e-16 1.84e-13
26 RESPONSE TO LIPID 31 888 1.685e-15 3.016e-13
27 EMBRYONIC ORGAN DEVELOPMENT 22 406 5.798e-15 9.993e-13
28 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 29 801 6.43e-15 1.069e-12
29 TUBE MORPHOGENESIS 20 323 9.081e-15 1.457e-12
30 POSITIVE REGULATION OF CELL PROLIFERATION 29 814 9.726e-15 1.509e-12
31 MAMMARY GLAND DEVELOPMENT 14 117 1.401e-14 2.103e-12
32 REGULATION OF CELLULAR COMPONENT MOVEMENT 28 771 1.898e-14 2.76e-12
33 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 42 1848 1.962e-14 2.767e-12
34 CANONICAL WNT SIGNALING PATHWAY 13 95 2.148e-14 2.855e-12
35 NEGATIVE REGULATION OF CELL COMMUNICATION 34 1192 2.089e-14 2.855e-12
36 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 14 122 2.54e-14 3.283e-12
37 UROGENITAL SYSTEM DEVELOPMENT 19 299 2.812e-14 3.537e-12
38 RESPONSE TO OXYGEN CONTAINING COMPOUND 36 1381 4.5e-14 5.51e-12
39 CELL FATE COMMITMENT 17 227 4.849e-14 5.786e-12
40 NEGATIVE REGULATION OF CELL DEATH 29 872 5.631e-14 6.55e-12
41 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 30 957 8.873e-14 1.007e-11
42 SKELETAL SYSTEM MORPHOGENESIS 16 201 1.094e-13 1.213e-11
43 WOUND HEALING 22 470 1.148e-13 1.242e-11
44 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 35 1360 1.634e-13 1.728e-11
45 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 32 1142 2.383e-13 2.464e-11
46 REGULATION OF CELL DEATH 36 1472 3.05e-13 3.085e-11
47 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 35 1395 3.427e-13 3.392e-11
48 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 38 1656 3.943e-13 3.822e-11
49 NEURON DIFFERENTIATION 28 874 4.129e-13 3.92e-11
50 RESPONSE TO WOUNDING 23 563 5.104e-13 4.749e-11
51 MAMMARY GLAND EPITHELIUM DEVELOPMENT 10 53 8.325e-13 7.595e-11
52 RESPONSE TO ALCOHOL 19 362 8.603e-13 7.698e-11
53 ANTERIOR POSTERIOR PATTERN SPECIFICATION 15 194 1.03e-12 9.041e-11
54 REGULATION OF PROTEIN MODIFICATION PROCESS 38 1710 1.062e-12 9.148e-11
55 DEVELOPMENTAL GROWTH 18 333 2.205e-12 1.866e-10
56 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 26 799 2.315e-12 1.923e-10
57 OSSIFICATION 16 251 3.362e-12 2.745e-10
58 RESPONSE TO HORMONE 27 893 4.487e-12 3.6e-10
59 REGULATION OF CELL ADHESION 23 629 4.957e-12 3.909e-10
60 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 28 983 6.915e-12 5.363e-10
61 POSITIVE REGULATION OF RESPONSE TO STIMULUS 39 1929 9.135e-12 6.968e-10
62 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 30 1152 9.96e-12 7.475e-10
63 RESPONSE TO GROWTH FACTOR 20 475 1.157e-11 8.544e-10
64 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 28 1008 1.251e-11 9.097e-10
65 REGULATION OF MAPK CASCADE 23 660 1.312e-11 9.39e-10
66 CENTRAL NERVOUS SYSTEM DEVELOPMENT 26 872 1.634e-11 1.152e-09
67 EMBRYONIC ORGAN MORPHOGENESIS 16 279 1.665e-11 1.156e-09
68 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 37 1784 1.793e-11 1.227e-09
69 NEGATIVE REGULATION OF CELL DIFFERENTIATION 22 609 1.936e-11 1.305e-09
70 REGULATION OF PHOSPHORUS METABOLIC PROCESS 35 1618 2.344e-11 1.558e-09
71 EPITHELIAL CELL DIFFERENTIATION 20 495 2.428e-11 1.591e-09
72 REGULATION OF ORGAN MORPHOGENESIS 15 242 2.485e-11 1.606e-09
73 RESPONSE TO STEROID HORMONE 20 497 2.61e-11 1.664e-09
74 REGULATION OF CELL DEVELOPMENT 25 836 4.024e-11 2.53e-09
75 HEAD DEVELOPMENT 23 709 5.495e-11 3.409e-09
76 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 27 1004 6.49e-11 3.974e-09
77 RESPONSE TO ESTROGEN 14 218 7.449e-11 4.502e-09
78 FORMATION OF PRIMARY GERM LAYER 11 110 7.711e-11 4.6e-09
79 REGULATION OF WNT SIGNALING PATHWAY 16 310 8.022e-11 4.725e-09
80 POSITIVE REGULATION OF MOLECULAR FUNCTION 36 1791 8.926e-11 5.192e-09
81 LOCOMOTION 28 1114 1.281e-10 7.359e-09
82 MESODERM DEVELOPMENT 11 118 1.661e-10 9.423e-09
83 POSITIVE REGULATION OF CELL DIFFERENTIATION 24 823 1.754e-10 9.833e-09
84 GASTRULATION 12 155 2.098e-10 1.162e-08
85 CONNECTIVE TISSUE DEVELOPMENT 13 194 2.173e-10 1.189e-08
86 INTRACELLULAR SIGNAL TRANSDUCTION 33 1572 2.253e-10 1.219e-08
87 CELL MOTILITY 24 835 2.352e-10 1.243e-08
88 LOCALIZATION OF CELL 24 835 2.352e-10 1.243e-08
89 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 10 93 2.807e-10 1.467e-08
90 KIDNEY EPITHELIUM DEVELOPMENT 11 125 3.104e-10 1.605e-08
91 MORPHOGENESIS OF A BRANCHING STRUCTURE 12 167 4.983e-10 2.548e-08
92 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 11 131 5.149e-10 2.604e-08
93 REPRODUCTIVE SYSTEM DEVELOPMENT 17 408 5.445e-10 2.724e-08
94 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 29 1275 5.828e-10 2.885e-08
95 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 20 602 7.629e-10 3.736e-08
96 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 27 1135 9.819e-10 4.759e-08
97 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 21 689 1.289e-09 6.182e-08
98 CARTILAGE DEVELOPMENT 11 147 1.767e-09 8.392e-08
99 POSITIVE REGULATION OF CELL COMMUNICATION 31 1532 2.229e-09 1.048e-07
100 CARDIOVASCULAR SYSTEM DEVELOPMENT 22 788 2.515e-09 1.159e-07
101 CIRCULATORY SYSTEM DEVELOPMENT 22 788 2.515e-09 1.159e-07
102 PROTEIN PHOSPHORYLATION 24 944 2.713e-09 1.238e-07
103 CELLULAR RESPONSE TO LIPID 17 457 3.027e-09 1.368e-07
104 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 25 1036 3.452e-09 1.53e-07
105 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 25 1036 3.452e-09 1.53e-07
106 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 17 465 3.925e-09 1.723e-07
107 DORSAL VENTRAL PATTERN FORMATION 9 91 4.803e-09 2.089e-07
108 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 30 1492 5.012e-09 2.159e-07
109 PHOSPHORYLATION 27 1228 5.358e-09 2.287e-07
110 OSTEOBLAST DIFFERENTIATION 10 126 5.647e-09 2.389e-07
111 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 21 750 5.783e-09 2.424e-07
112 POSITIVE REGULATION OF LOCOMOTION 16 420 6.549e-09 2.721e-07
113 MESODERM MORPHOGENESIS 8 66 6.931e-09 2.854e-07
114 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 30 1517 7.351e-09 2.974e-07
115 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 15 365 7.327e-09 2.974e-07
116 CELL DEATH 24 1001 8.5e-09 3.409e-07
117 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 10 134 1.026e-08 4.079e-07
118 POSITIVE REGULATION OF CELL ADHESION 15 376 1.091e-08 4.3e-07
119 NON CANONICAL WNT SIGNALING PATHWAY 10 140 1.564e-08 6.117e-07
120 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 10 144 2.05e-08 7.949e-07
121 RESPONSE TO ESTRADIOL 10 146 2.34e-08 8.997e-07
122 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 12 236 2.498e-08 9.529e-07
123 CELLULAR COMPONENT MORPHOGENESIS 22 900 2.775e-08 1.05e-06
124 NEURAL TUBE DEVELOPMENT 10 149 2.842e-08 1.066e-06
125 CELL PROLIFERATION 19 672 2.869e-08 1.068e-06
126 REGULATION OF STEM CELL DIFFERENTIATION 9 113 3.267e-08 1.207e-06
127 REGULATION OF EMBRYONIC DEVELOPMENT 9 114 3.529e-08 1.293e-06
128 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 11 197 3.776e-08 1.373e-06
129 NEPHRON DEVELOPMENT 9 115 3.809e-08 1.374e-06
130 KIDNEY MORPHOGENESIS 8 82 3.963e-08 1.418e-06
131 NEURON DEVELOPMENT 19 687 4.068e-08 1.445e-06
132 REGULATION OF CELL MORPHOGENESIS 17 552 4.875e-08 1.719e-06
133 SENSORY ORGAN DEVELOPMENT 16 493 6.115e-08 2.139e-06
134 REPRODUCTION 26 1297 7.023e-08 2.439e-06
135 NEGATIVE REGULATION OF GENE EXPRESSION 28 1493 8.066e-08 2.78e-06
136 MESONEPHROS DEVELOPMENT 8 90 8.273e-08 2.83e-06
137 IMMUNE SYSTEM DEVELOPMENT 17 582 1.042e-07 3.488e-06
138 REGULATION OF SMOOTHENED SIGNALING PATHWAY 7 62 1.041e-07 3.488e-06
139 TUBE FORMATION 9 129 1.033e-07 3.488e-06
140 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 16 513 1.053e-07 3.5e-06
141 NEPHRON EPITHELIUM DEVELOPMENT 8 93 1.07e-07 3.532e-06
142 REGULATION OF HYDROLASE ACTIVITY 26 1327 1.104e-07 3.617e-06
143 CELL PROJECTION ORGANIZATION 21 902 1.362e-07 4.431e-06
144 GLAND MORPHOGENESIS 8 97 1.488e-07 4.809e-06
145 FOREBRAIN GENERATION OF NEURONS 7 66 1.615e-07 5.148e-06
146 RESPONSE TO VITAMIN 8 98 1.612e-07 5.148e-06
147 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 13 337 1.629e-07 5.156e-06
148 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 7 67 1.795e-07 5.642e-06
149 REGULATION OF EPITHELIAL CELL PROLIFERATION 12 285 1.962e-07 6.127e-06
150 PEPTIDYL AMINO ACID MODIFICATION 20 841 2.008e-07 6.228e-06
151 POSITIVE REGULATION OF DNA METABOLIC PROCESS 10 185 2.185e-07 6.733e-06
152 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 17 616 2.33e-07 7.132e-06
153 NEURON PROJECTION DEVELOPMENT 16 545 2.387e-07 7.26e-06
154 ODONTOGENESIS 8 105 2.756e-07 8.327e-06
155 MESENCHYME DEVELOPMENT 10 190 2.799e-07 8.348e-06
156 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 10 190 2.799e-07 8.348e-06
157 RESPONSE TO NUTRIENT 10 191 2.938e-07 8.708e-06
158 REGULATION OF TRANSFERASE ACTIVITY 21 946 2.998e-07 8.829e-06
159 FOREBRAIN DEVELOPMENT 13 357 3.151e-07 9.22e-06
160 EAR DEVELOPMENT 10 195 3.559e-07 1.035e-05
161 REGULATION OF CYTOKINE PRODUCTION 16 563 3.687e-07 1.066e-05
162 NEGATIVE REGULATION OF CELL DEVELOPMENT 12 303 3.781e-07 1.086e-05
163 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 10 197 3.91e-07 1.116e-05
164 REGULATION OF ESTABLISHMENT OF PLANAR POLARITY 8 110 3.947e-07 1.12e-05
165 POSITIVE REGULATION OF CATALYTIC ACTIVITY 27 1518 4.172e-07 1.176e-05
166 NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 4 11 4.348e-07 1.219e-05
167 EAR MORPHOGENESIS 8 112 4.535e-07 1.263e-05
168 IN UTERO EMBRYONIC DEVELOPMENT 12 311 4.989e-07 1.382e-05
169 RENAL TUBULE DEVELOPMENT 7 78 5.156e-07 1.419e-05
170 BONE DEVELOPMENT 9 156 5.23e-07 1.431e-05
171 CELLULAR RESPONSE TO ALCOHOL 8 115 5.555e-07 1.512e-05
172 BONE MORPHOGENESIS 7 79 5.628e-07 1.523e-05
173 METANEPHROS DEVELOPMENT 7 81 6.683e-07 1.798e-05
174 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 9 162 7.186e-07 1.911e-05
175 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 9 162 7.186e-07 1.911e-05
176 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 6 53 8.674e-07 2.293e-05
177 POSITIVE REGULATION OF TRANSPORT 20 936 1.08e-06 2.838e-05
178 HEART DEVELOPMENT 14 466 1.089e-06 2.848e-05
179 NEGATIVE REGULATION OF CELL ADHESION 10 223 1.214e-06 3.157e-05
180 RESPONSE TO NITROGEN COMPOUND 19 859 1.246e-06 3.217e-05
181 REGULATION OF KINASE ACTIVITY 18 776 1.251e-06 3.217e-05
182 REGULATION OF DNA METABOLIC PROCESS 12 340 1.276e-06 3.262e-05
183 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 8 129 1.333e-06 3.377e-05
184 REGULATION OF CELL CYCLE 20 949 1.336e-06 3.377e-05
185 REGULATION OF PROTEIN LOCALIZATION 20 950 1.357e-06 3.414e-05
186 GLIOGENESIS 9 175 1.37e-06 3.426e-05
187 RESPONSE TO EXTERNAL STIMULUS 29 1821 1.389e-06 3.456e-05
188 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 10 228 1.484e-06 3.673e-05
189 RESPONSE TO INORGANIC SUBSTANCE 14 479 1.506e-06 3.707e-05
190 CELLULAR RESPONSE TO HORMONE STIMULUS 15 552 1.535e-06 3.758e-05
191 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 10 229 1.544e-06 3.761e-05
192 INNER EAR MORPHOGENESIS 7 92 1.592e-06 3.859e-05
193 REGULATION OF NEURON DIFFERENTIATION 15 554 1.605e-06 3.869e-05
194 POSITIVE REGULATION OF KINASE ACTIVITY 14 482 1.62e-06 3.885e-05
195 MUSCLE CELL DIFFERENTIATION 10 237 2.103e-06 5.018e-05
196 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 17 724 2.16e-06 5.129e-05
197 CELL ACTIVATION 15 568 2.182e-06 5.132e-05
198 REGULATION OF ERK1 AND ERK2 CASCADE 10 238 2.184e-06 5.132e-05
199 PLACENTA DEVELOPMENT 8 138 2.215e-06 5.18e-05
200 SENSORY ORGAN MORPHOGENESIS 10 239 2.267e-06 5.275e-05
201 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 15 573 2.429e-06 5.623e-05
202 NEGATIVE REGULATION OF MOLECULAR FUNCTION 21 1079 2.491e-06 5.739e-05
203 IMMUNE SYSTEM PROCESS 30 1984 2.545e-06 5.833e-05
204 MUSCLE STRUCTURE DEVELOPMENT 13 432 2.654e-06 6.054e-05
205 POSITIVE REGULATION OF HYDROLASE ACTIVITY 19 905 2.683e-06 6.091e-05
206 STEM CELL DIFFERENTIATION 9 190 2.703e-06 6.106e-05
207 REGULATION OF ORGANELLE ORGANIZATION 22 1178 2.719e-06 6.112e-05
208 EXTRACELLULAR STRUCTURE ORGANIZATION 11 304 2.844e-06 6.362e-05
209 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 14 514 3.419e-06 7.612e-05
210 NEURON FATE COMMITMENT 6 67 3.515e-06 7.789e-05
211 POSITIVE REGULATION OF PROTEIN IMPORT 7 104 3.633e-06 7.975e-05
212 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 7 104 3.633e-06 7.975e-05
213 MALE SEX DIFFERENTIATION 8 148 3.736e-06 8.162e-05
214 NERVE DEVELOPMENT 6 68 3.836e-06 8.341e-05
215 NEPHRON TUBULE FORMATION 4 18 3.899e-06 8.439e-05
216 ERBB2 SIGNALING PATHWAY 5 39 3.948e-06 8.505e-05
217 REGULATION OF CELL CELL ADHESION 12 380 4.026e-06 8.632e-05
218 REGULATION OF FAT CELL DIFFERENTIATION 7 106 4.126e-06 8.807e-05
219 RESPONSE TO ABIOTIC STIMULUS 20 1024 4.238e-06 9.005e-05
220 MAMMARY GLAND MORPHOGENESIS 5 40 4.49e-06 9.495e-05
221 RESPONSE TO ACID CHEMICAL 11 319 4.51e-06 9.495e-05
222 CELL FATE SPECIFICATION 6 71 4.945e-06 0.0001036
223 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 8 154 5.018e-06 0.0001047
224 REGULATION OF CELLULAR RESPONSE TO STRESS 16 691 5.276e-06 0.0001096
225 NEGATIVE REGULATION OF LOCOMOTION 10 263 5.31e-06 0.0001098
226 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 9 207 5.443e-06 0.0001121
227 SEX DIFFERENTIATION 10 266 5.868e-06 0.0001203
228 BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS 4 20 6.115e-06 0.0001248
229 REGULATION OF JNK CASCADE 8 159 6.354e-06 0.0001291
230 CRANIAL NERVE DEVELOPMENT 5 43 6.473e-06 0.0001309
231 POSITIVE REGULATION OF CELL CYCLE 11 332 6.59e-06 0.0001327
232 POSITIVE REGULATION OF CELL DEVELOPMENT 13 472 6.935e-06 0.0001391
233 REGENERATION 8 161 6.966e-06 0.0001391
234 NEURON PROJECTION MORPHOGENESIS 12 402 7.13e-06 0.0001418
235 BODY MORPHOGENESIS 5 44 7.267e-06 0.0001439
236 RESPONSE TO CYTOKINE 16 714 7.961e-06 0.000157
237 CELL PART MORPHOGENESIS 15 633 8.085e-06 0.0001581
238 REGULATION OF GROWTH 15 633 8.085e-06 0.0001581
239 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 9 218 8.273e-06 0.0001611
240 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 8 166 8.72e-06 0.0001685
241 REGULATION OF CELL CYCLE PROCESS 14 558 8.729e-06 0.0001685
242 BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY 4 22 9.145e-06 0.0001758
243 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 7 121 9.908e-06 0.0001889
244 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 7 121 9.908e-06 0.0001889
245 CRANIAL NERVE MORPHOGENESIS 4 23 1.102e-05 0.0002087
246 ENDOCRINE SYSTEM DEVELOPMENT 7 123 1.103e-05 0.0002087
247 NEGATIVE REGULATION OF PHOSPHORYLATION 12 422 1.161e-05 0.0002183
248 INOSITOL LIPID MEDIATED SIGNALING 7 124 1.163e-05 0.0002183
249 APOPTOTIC SIGNALING PATHWAY 10 289 1.211e-05 0.0002263
250 EMBRYONIC PLACENTA DEVELOPMENT 6 83 1.227e-05 0.0002284
251 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 16 740 1.242e-05 0.0002302
252 CELLULAR RESPONSE TO ACID CHEMICAL 8 175 1.282e-05 0.0002358
253 HOMEOSTASIS OF NUMBER OF CELLS 8 175 1.282e-05 0.0002358
254 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 5 50 1.377e-05 0.0002522
255 PALATE DEVELOPMENT 6 85 1.408e-05 0.0002569
256 RESPONSE TO DRUG 12 431 1.432e-05 0.0002603
257 REGULATION OF OSSIFICATION 8 178 1.45e-05 0.0002626
258 POSITIVE REGULATION OF DNA REPLICATION 6 86 1.506e-05 0.0002706
259 REGULATION OF REPRODUCTIVE PROCESS 7 129 1.506e-05 0.0002706
260 FOREBRAIN REGIONALIZATION 4 25 1.559e-05 0.0002769
261 REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 4 25 1.559e-05 0.0002769
262 PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 4 25 1.559e-05 0.0002769
263 CELL CYCLE 22 1316 1.579e-05 0.0002793
264 TISSUE REGENERATION 5 52 1.672e-05 0.0002947
265 BIOLOGICAL ADHESION 19 1032 1.741e-05 0.0003057
266 REGULATION OF PROTEIN IMPORT 8 183 1.772e-05 0.00031
267 RESPONSE TO EXTRACELLULAR STIMULUS 12 441 1.797e-05 0.0003132
268 POSITIVE REGULATION OF CYTOKINE PRODUCTION 11 370 1.815e-05 0.0003152
269 REGULATION OF MESONEPHROS DEVELOPMENT 4 26 1.834e-05 0.0003154
270 MESONEPHRIC TUBULE MORPHOGENESIS 5 53 1.837e-05 0.0003154
271 SEGMENTATION 6 89 1.834e-05 0.0003154
272 AXIS SPECIFICATION 6 90 1.955e-05 0.0003344
273 EPITHELIAL CELL DEVELOPMENT 8 186 1.993e-05 0.0003397
274 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 28 1977 2.038e-05 0.000345
275 REGULATION OF PROTEIN TARGETING 10 307 2.039e-05 0.000345
276 GLIAL CELL DIFFERENTIATION 7 136 2.123e-05 0.0003578
277 CELLULAR RESPONSE TO CYTOKINE STIMULUS 14 606 2.192e-05 0.0003683
278 CRANIAL SKELETAL SYSTEM DEVELOPMENT 5 55 2.205e-05 0.0003691
279 POSITIVE REGULATION OF CELL CYCLE PROCESS 9 247 2.238e-05 0.0003732
280 REGULATION OF ACTIN FILAMENT BASED PROCESS 10 312 2.341e-05 0.0003891
281 RESPONSE TO BMP 6 94 2.506e-05 0.0004105
282 NEURAL TUBE FORMATION 6 94 2.506e-05 0.0004105
283 CELLULAR RESPONSE TO BMP STIMULUS 6 94 2.506e-05 0.0004105
284 MAMMARY GLAND DUCT MORPHOGENESIS 4 28 2.488e-05 0.0004105
285 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 6 95 2.661e-05 0.0004345
286 CELL CYCLE PHASE TRANSITION 9 255 2.875e-05 0.0004677
287 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 13 541 2.924e-05 0.0004724
288 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 13 541 2.924e-05 0.0004724
289 REGULATION OF CELL GROWTH 11 391 3.015e-05 0.0004837
290 RESPIRATORY SYSTEM DEVELOPMENT 8 197 3.01e-05 0.0004837
291 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 9 258 3.15e-05 0.000502
292 REGULATION OF PROTEOLYSIS 15 711 3.149e-05 0.000502
293 REGULATION OF TRANSPORT 26 1804 3.205e-05 0.0005089
294 REGULATION OF CELLULAR LOCALIZATION 21 1277 3.229e-05 0.000511
295 LEUKOCYTE MIGRATION 9 259 3.247e-05 0.0005122
296 POSITIVE REGULATION OF MAPK CASCADE 12 470 3.354e-05 0.0005255
297 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 12 470 3.354e-05 0.0005255
298 CHONDROCYTE DIFFERENTIATION 5 60 3.378e-05 0.0005275
299 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 19 1087 3.553e-05 0.0005522
300 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 6 100 3.56e-05 0.0005522
301 URETER DEVELOPMENT 3 11 3.613e-05 0.0005548
302 BONE TRABECULA MORPHOGENESIS 3 11 3.613e-05 0.0005548
303 PROSTATE GLANDULAR ACINUS DEVELOPMENT 3 11 3.613e-05 0.0005548
304 PEPTIDYL SERINE MODIFICATION 7 148 3.657e-05 0.000558
305 DIGESTIVE SYSTEM DEVELOPMENT 7 148 3.657e-05 0.000558
306 NEURON PROJECTION GUIDANCE 8 205 3.995e-05 0.0006075
307 RESPONSE TO METAL ION 10 333 4.069e-05 0.0006147
308 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 11 404 4.058e-05 0.0006147
309 REGULATION OF MUSCLE TISSUE DEVELOPMENT 6 103 4.207e-05 0.0006294
310 REGULATION OF MUSCLE ORGAN DEVELOPMENT 6 103 4.207e-05 0.0006294
311 NEGATIVE REGULATION OF CELL PROLIFERATION 14 643 4.189e-05 0.0006294
312 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 7 152 4.336e-05 0.0006467
313 CARDIAC CHAMBER MORPHOGENESIS 6 104 4.442e-05 0.0006603
314 RESPONSE TO MECHANICAL STIMULUS 8 210 4.739e-05 0.0007022
315 MAMMARY GLAND EPITHELIAL CELL PROLIFERATION 3 12 4.796e-05 0.0007084
316 SKIN DEVELOPMENT 8 211 4.9e-05 0.0007216
317 RESPONSE TO RADIATION 11 413 4.952e-05 0.0007269
318 PROTEIN COMPLEX SUBUNIT ORGANIZATION 23 1527 5.1e-05 0.0007462
319 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 8 213 5.238e-05 0.000764
320 SOMATIC STEM CELL POPULATION MAINTENANCE 5 66 5.368e-05 0.0007806
321 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 4 34 5.476e-05 0.0007938
322 RESPONSE TO HYDROGEN PEROXIDE 6 109 5.782e-05 0.0008329
323 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 8 216 5.78e-05 0.0008329
324 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 12 498 5.86e-05 0.0008416
325 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 8 218 6.166e-05 0.0008828
326 ORGAN GROWTH 5 68 6.2e-05 0.000885
327 RESPONSE TO OXIDATIVE STRESS 10 352 6.475e-05 0.0009213
328 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 8 220 6.574e-05 0.0009326
329 CELLULAR RESPONSE TO NITROGEN COMPOUND 12 505 6.695e-05 0.0009469
330 HEAD MORPHOGENESIS 4 36 6.89e-05 0.0009715
331 REGULATION OF CELLULAR COMPONENT BIOGENESIS 15 767 7.435e-05 0.001045
332 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 9 289 7.577e-05 0.001062
333 ENDODERM DEVELOPMENT 5 71 7.632e-05 0.001066
334 NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 4 37 7.689e-05 0.001071
335 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 10 360 7.802e-05 0.001084
336 REGULATION OF ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE 3 14 7.863e-05 0.001086
337 CRANIOFACIAL SUTURE MORPHOGENESIS 3 14 7.863e-05 0.001086
338 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 11 437 8.206e-05 0.001128
339 REGULATION OF RESPONSE TO STRESS 22 1468 8.216e-05 0.001128
340 POSITIVE REGULATION OF DNA REPAIR 4 38 8.553e-05 0.00117
341 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 10 368 9.354e-05 0.001276
342 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 16 876 9.402e-05 0.001279
343 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 7 172 9.466e-05 0.001284
344 REGULATION OF LEUKOCYTE DIFFERENTIATION 8 232 9.522e-05 0.001288
345 MESENCHYMAL TO EPITHELIAL TRANSITION 3 15 9.785e-05 0.001301
346 STRIATED MUSCLE CELL DIFFERENTIATION 7 173 9.816e-05 0.001301
347 GABAERGIC NEURON DIFFERENTIATION 3 15 9.785e-05 0.001301
348 NOSE DEVELOPMENT 3 15 9.785e-05 0.001301
349 REGULATION OF CELL SUBSTRATE ADHESION 7 173 9.816e-05 0.001301
350 RESPONSE TO TUMOR NECROSIS FACTOR 8 233 9.81e-05 0.001301
351 REGULATION OF VASCULATURE DEVELOPMENT 8 233 9.81e-05 0.001301
352 ENDODERMAL CELL DIFFERENTIATION 4 40 0.0001049 0.001383
353 NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION 4 40 0.0001049 0.001383
354 EXTRACELLULAR MATRIX DISASSEMBLY 5 76 0.0001057 0.001389
355 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 6 122 0.0001082 0.001414
356 CELL CYCLE PROCESS 18 1081 0.0001082 0.001414
357 REGULATION OF BMP SIGNALING PATHWAY 5 77 0.0001125 0.001466
358 POSITIVE REGULATION OF GROWTH 8 238 0.0001136 0.001477
359 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 4 41 0.0001157 0.001487
360 NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE 4 41 0.0001157 0.001487
361 NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 4 41 0.0001157 0.001487
362 PROSTATE GLAND DEVELOPMENT 4 41 0.0001157 0.001487
363 REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION 3 16 0.0001199 0.001528
364 MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION 3 16 0.0001199 0.001528
365 SOMITE DEVELOPMENT 5 78 0.0001196 0.001528
366 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 10 381 0.0001243 0.001581
367 MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS 5 79 0.000127 0.001605
368 ERBB SIGNALING PATHWAY 5 79 0.000127 0.001605
369 EPITHELIAL CELL MORPHOGENESIS 4 42 0.0001273 0.001605
370 POSITIVE REGULATION OF CELL CELL ADHESION 8 243 0.0001311 0.001649
371 TAXIS 11 464 0.0001391 0.001744
372 NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION 4 43 0.0001396 0.001747
373 MUSCLE CELL DEVELOPMENT 6 128 0.0001408 0.001757
374 NEGATIVE REGULATION OF KIDNEY DEVELOPMENT 3 17 0.0001449 0.001789
375 DORSAL VENTRAL NEURAL TUBE PATTERNING 3 17 0.0001449 0.001789
376 MAMMARY GLAND ALVEOLUS DEVELOPMENT 3 17 0.0001449 0.001789
377 MAMMARY GLAND LOBULE DEVELOPMENT 3 17 0.0001449 0.001789
378 CELL JUNCTION ORGANIZATION 7 185 0.0001489 0.001833
379 NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 5 82 0.0001516 0.001861
380 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 4 44 0.0001529 0.001872
381 REGULATION OF CELLULAR PROTEIN LOCALIZATION 12 552 0.0001546 0.001888
382 REGULATION OF PEPTIDASE ACTIVITY 10 392 0.0001567 0.001909
383 REGULATION OF LYMPHOCYTE DIFFERENTIATION 6 132 0.0001667 0.00202
384 MAINTENANCE OF CELL NUMBER 6 132 0.0001667 0.00202
385 MYELOID CELL DIFFERENTIATION 7 189 0.0001699 0.002054
386 ORGAN MATURATION 3 18 0.0001731 0.002066
387 REGULATION OF INTERLEUKIN 13 PRODUCTION 3 18 0.0001731 0.002066
388 CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS 3 18 0.0001731 0.002066
389 KIDNEY MESENCHYME DEVELOPMENT 3 18 0.0001731 0.002066
390 SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION 3 18 0.0001731 0.002066
391 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 15 829 0.0001751 0.002083
392 MESENCHYMAL CELL DIFFERENTIATION 6 134 0.0001809 0.002147
393 RESPONSE TO REACTIVE OXYGEN SPECIES 7 191 0.0001813 0.002147
394 PROTEIN AUTOPHOSPHORYLATION 7 192 0.0001872 0.002211
395 CELL GROWTH 6 135 0.0001884 0.002219
396 DEVELOPMENTAL MATURATION 7 193 0.0001933 0.002271
397 NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 6 136 0.0001961 0.002298
398 CYTOSKELETON ORGANIZATION 15 838 0.0001968 0.0023
399 THYMUS DEVELOPMENT 4 47 0.000198 0.002309
400 CELL CYCLE CHECKPOINT 7 194 0.0001995 0.002321
401 CELLULAR RESPONSE TO RADIATION 6 137 0.0002041 0.002368
402 REGULATION OF INTERLEUKIN 5 PRODUCTION 3 19 0.0002047 0.002369
403 CELLULAR RESPONSE TO STRESS 22 1565 0.0002066 0.002386
404 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 10 406 0.000208 0.002395
405 CELLULAR RESPONSE TO INTERLEUKIN 1 5 88 0.0002113 0.002422
406 NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 5 88 0.0002113 0.002422
407 CELL CYCLE G2 M PHASE TRANSITION 6 138 0.0002123 0.002427
408 DIGESTIVE TRACT MORPHOGENESIS 4 48 0.000215 0.002452
409 CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 6 139 0.0002207 0.002511
410 CELLULAR RESPONSE TO ABIOTIC STIMULUS 8 263 0.000225 0.002554
411 AGING 8 264 0.0002309 0.002614
412 POSITIVE REGULATION OF CHEMOKINE PRODUCTION 4 49 0.000233 0.002632
413 PROTEIN LOCALIZATION 24 1805 0.0002362 0.002661
414 TONGUE DEVELOPMENT 3 20 0.0002397 0.002681
415 BONE GROWTH 3 20 0.0002397 0.002681
416 DORSAL VENTRAL AXIS SPECIFICATION 3 20 0.0002397 0.002681
417 ENDODERM FORMATION 4 50 0.0002521 0.002806
418 RHO PROTEIN SIGNAL TRANSDUCTION 4 50 0.0002521 0.002806
419 CARDIAC CHAMBER DEVELOPMENT 6 144 0.0002672 0.00296
420 CELL CELL SIGNALING 14 767 0.0002668 0.00296
421 REGULATION OF DNA BINDING 5 93 0.0002736 0.003016
422 MULTICELLULAR ORGANISM METABOLIC PROCESS 5 93 0.0002736 0.003016
423 RESPONSE TO IONIZING RADIATION 6 145 0.0002774 0.003041
424 CHONDROCYTE DEVELOPMENT 3 21 0.0002784 0.003041
425 NEGATIVE REGULATION OF MAPK CASCADE 6 145 0.0002774 0.003041
426 COCHLEA MORPHOGENESIS 3 21 0.0002784 0.003041
427 POSITIVE REGULATION OF CELL GROWTH 6 148 0.0003096 0.003374
428 REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS 4 53 0.000316 0.003435
429 MYELOID LEUKOCYTE DIFFERENTIATION 5 96 0.0003171 0.003439
430 POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT 3 22 0.0003209 0.003473
431 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 9 352 0.0003312 0.003575
432 NEGATIVE REGULATION OF CYTOKINE PRODUCTION 7 211 0.0003327 0.003583
433 CELLULAR COMPONENT DISASSEMBLY 11 515 0.0003408 0.003662
434 HEART MORPHOGENESIS 7 212 0.0003423 0.00367
435 NEGATIVE REGULATION OF CELL CYCLE 10 433 0.000347 0.003712
436 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 6 152 0.0003572 0.003812
437 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 8 282 0.0003596 0.003828
438 PROSTATE GLAND MORPHOGENESIS 3 23 0.0003674 0.003867
439 NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 3 23 0.0003674 0.003867
440 REGULATION OF KIDNEY DEVELOPMENT 4 55 0.0003646 0.003867
441 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE III PROMOTER 3 23 0.0003674 0.003867
442 TRABECULA FORMATION 3 23 0.0003674 0.003867
443 REGULATION OF BINDING 8 283 0.0003681 0.003867
444 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 6 153 0.0003699 0.003876
445 CELL CELL ADHESION 12 608 0.0003732 0.003903
446 REGULATION OF HISTONE METHYLATION 4 56 0.0003908 0.004077
447 PROTEIN LOCALIZATION TO NUCLEUS 6 156 0.0004102 0.00427
448 REGULATION OF APOPTOTIC SIGNALING PATHWAY 9 363 0.0004142 0.004302
449 CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS 3 24 0.000418 0.004313
450 RESPONSE TO STEROL 3 24 0.000418 0.004313
451 POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY 3 24 0.000418 0.004313
452 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 12 616 0.0004196 0.004319
453 REGULATION OF DEVELOPMENTAL GROWTH 8 289 0.0004232 0.004347
454 LEUKOCYTE DIFFERENTIATION 8 292 0.0004532 0.004644
455 CELLULAR RESPONSE TO EPIDERMAL GROWTH FACTOR STIMULUS 3 25 0.0004729 0.004804
456 RESPONSE TO PROSTAGLANDIN E 3 25 0.0004729 0.004804
457 CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT 3 25 0.0004729 0.004804
458 NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY 3 25 0.0004729 0.004804
459 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 9 370 0.0004755 0.004821
460 REGULATION OF DNA REPLICATION 6 161 0.000485 0.004906
461 SPINAL CORD DEVELOPMENT 5 106 0.0005006 0.005042
462 CARDIAC VENTRICLE DEVELOPMENT 5 106 0.0005006 0.005042
463 REGULATION OF GLUCOSE IMPORT 4 60 0.0005091 0.005116
464 POSITIVE REGULATION OF HEMOPOIESIS 6 163 0.0005178 0.005175
465 HOMEOSTATIC PROCESS 19 1337 0.0005173 0.005175
466 RHYTHMIC PROCESS 8 298 0.0005182 0.005175
467 RESPONSE TO RETINOIC ACID 5 107 0.0005226 0.005207
468 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 3 26 0.0005322 0.005258
469 MESODERMAL CELL DIFFERENTIATION 3 26 0.0005322 0.005258
470 CELLULAR RESPONSE TO VITAMIN 3 26 0.0005322 0.005258
471 POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 3 26 0.0005322 0.005258
472 CELLULAR RESPONSE TO HYDROGEN PEROXIDE 4 61 0.0005422 0.005334
473 POSITIVE REGULATION OF STEM CELL PROLIFERATION 4 61 0.0005422 0.005334
474 REGULATION OF CELL CYCLE ARREST 5 108 0.0005453 0.005353
475 CELL DIVISION 10 460 0.0005566 0.005452
476 PROTEIN COMPLEX BIOGENESIS 17 1132 0.0005655 0.005516
477 PROTEIN COMPLEX ASSEMBLY 17 1132 0.0005655 0.005516
478 SOMITOGENESIS 4 62 0.0005769 0.005604
479 CARDIAC VENTRICLE MORPHOGENESIS 4 62 0.0005769 0.005604
480 SKELETAL MUSCLE TISSUE REGENERATION 3 27 0.000596 0.005742
481 REGULATION OF CARDIAC MUSCLE CELL CONTRACTION 3 27 0.000596 0.005742
482 REGULATION OF HISTONE H3 K4 METHYLATION 3 27 0.000596 0.005742
483 RESPONSE TO LITHIUM ION 3 27 0.000596 0.005742
484 APPENDAGE DEVELOPMENT 6 169 0.0006264 0.006009
485 LIMB DEVELOPMENT 6 169 0.0006264 0.006009
486 REGULATION OF MITOTIC CELL CYCLE 10 468 0.0006358 0.006087
487 REGULATION OF OSTEOBLAST DIFFERENTIATION 5 112 0.0006436 0.006149
488 VASCULATURE DEVELOPMENT 10 469 0.0006463 0.006162
489 REGULATION OF PROTEIN ACETYLATION 4 64 0.0006509 0.006181
490 POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 4 64 0.0006509 0.006181
491 REGULATION OF CELL PROJECTION ORGANIZATION 11 558 0.0006653 0.006263
492 HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS 3 28 0.0006646 0.006263
493 NEGATIVE REGULATION OF NEURON DEATH 6 171 0.0006662 0.006263
494 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 6 171 0.0006662 0.006263
495 METANEPHROS MORPHOGENESIS 3 28 0.0006646 0.006263
496 PROTEIN HETEROOLIGOMERIZATION 5 113 0.0006701 0.006287
497 CELLULAR RESPONSE TO RETINOIC ACID 4 65 0.0006903 0.006437
498 REGULATION OF CHEMOKINE PRODUCTION 4 65 0.0006903 0.006437
499 REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 4 65 0.0006903 0.006437
500 RESPONSE TO INTERLEUKIN 1 5 115 0.0007256 0.006753
501 REGULATION OF HEMOPOIESIS 8 314 0.0007295 0.006775
502 POSITIVE REGULATION OF LIPASE ACTIVITY 4 66 0.0007314 0.006779
503 T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE 3 29 0.000738 0.006813
504 EMBRYONIC HINDLIMB MORPHOGENESIS 3 29 0.000738 0.006813
505 RESPONSE TO CORTICOSTEROID 6 176 0.0007745 0.007136
506 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 5 117 0.0007845 0.007214
507 NEGATIVE REGULATION OF HYDROLASE ACTIVITY 9 397 0.000786 0.007214
508 REGULATION OF MAP KINASE ACTIVITY 8 319 0.0008082 0.007403
509 RESPONSE TO EPIDERMAL GROWTH FACTOR 3 30 0.0008163 0.007447
510 CELLULAR RESPONSE TO ESTRADIOL STIMULUS 3 30 0.0008163 0.007447
511 REGULATION OF CELL CYCLE PHASE TRANSITION 8 321 0.0008415 0.007663
512 PERIPHERAL NERVOUS SYSTEM DEVELOPMENT 4 69 0.000865 0.007861
513 MITOTIC CELL CYCLE 13 766 0.0008776 0.00796
514 REGULATION OF INTERLEUKIN 4 PRODUCTION 3 31 0.0008997 0.008066
515 RESPONSE TO INTERLEUKIN 4 3 31 0.0008997 0.008066
516 NEURON FATE SPECIFICATION 3 31 0.0008997 0.008066
517 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 3 31 0.0008997 0.008066
518 SCHWANN CELL DIFFERENTIATION 3 31 0.0008997 0.008066
519 MATERNAL PLACENTA DEVELOPMENT 3 31 0.0008997 0.008066
520 RESPONSE TO KETONE 6 182 0.0009219 0.00825
521 EYE DEVELOPMENT 8 326 0.0009297 0.008303
522 REGULATION OF NEURON DEATH 7 252 0.0009535 0.008499
523 SKIN EPIDERMIS DEVELOPMENT 4 71 0.000963 0.008568
524 CELLULAR RESPONSE TO OXIDATIVE STRESS 6 184 0.0009756 0.008663
525 ENDOCARDIAL CUSHION DEVELOPMENT 3 32 0.0009883 0.008677
526 POSITIVE REGULATION OF MITOTIC CELL CYCLE 5 123 0.0009825 0.008677
527 POSITIVE REGULATION OF BMP SIGNALING PATHWAY 3 32 0.0009883 0.008677
528 PROXIMAL DISTAL PATTERN FORMATION 3 32 0.0009883 0.008677
529 REGULATION OF ACTIN FILAMENT BASED MOVEMENT 3 32 0.0009883 0.008677
530 T CELL DIFFERENTIATION 5 123 0.0009825 0.008677
531 PEPTIDYL TYROSINE MODIFICATION 6 186 0.001032 0.00904
532 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 12 684 0.001049 0.009175
533 LEUKOCYTE ACTIVATION 9 414 0.001055 0.009203
534 STEROID HORMONE MEDIATED SIGNALING PATHWAY 5 125 0.001056 0.009203
535 ERYTHROCYTE HOMEOSTASIS 4 73 0.001069 0.009277
536 CELLULAR RESPONSE TO KETONE 4 73 0.001069 0.009277
537 REGULATION OF CYTOSKELETON ORGANIZATION 10 502 0.001084 0.009391
538 RESPONSE TO UV 5 126 0.001094 0.009466
539 SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 5 127 0.001134 0.009788
NumGOOverlapSizeP ValueAdj. P Value
1 PROTEIN KINASE ACTIVITY 20 640 2.185e-09 1.037e-06
2 TRANSCRIPTION FACTOR BINDING 18 524 3.491e-09 1.037e-06
3 SEQUENCE SPECIFIC DNA BINDING 25 1037 3.52e-09 1.037e-06
4 GROWTH FACTOR BINDING 10 123 4.465e-09 1.037e-06
5 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 19 629 9.976e-09 1.853e-06
6 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 14 328 1.492e-08 2.31e-06
7 BETA CATENIN BINDING 8 84 4.798e-08 5.571e-06
8 KINASE ACTIVITY 21 842 4.268e-08 5.571e-06
9 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 13 315 7.46e-08 6.93e-06
10 CHROMATIN BINDING 15 435 7.458e-08 6.93e-06
11 REGULATORY REGION NUCLEIC ACID BINDING 20 818 1.287e-07 1.087e-05
12 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 11 226 1.529e-07 1.183e-05
13 MACROMOLECULAR COMPLEX BINDING 26 1399 3.092e-07 2.21e-05
14 CORE PROMOTER PROXIMAL REGION DNA BINDING 13 371 4.874e-07 3.234e-05
15 PROTEIN SERINE THREONINE KINASE ACTIVITY 14 445 6.305e-07 3.779e-05
16 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 21 992 6.509e-07 3.779e-05
17 DOUBLE STRANDED DNA BINDING 18 764 1.002e-06 5.475e-05
18 RECEPTOR BINDING 25 1476 2.953e-06 0.0001524
19 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 22 1199 3.619e-06 0.000177
20 SULFUR COMPOUND BINDING 9 234 1.458e-05 0.0006451
21 IDENTICAL PROTEIN BINDING 21 1209 1.433e-05 0.0006451
22 ENZYME BINDING 26 1737 1.666e-05 0.0007034
23 RIBONUCLEOTIDE BINDING 27 1860 1.918e-05 0.0007747
24 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 6 104 4.442e-05 0.001719
25 MAP KINASE ACTIVITY 3 14 7.863e-05 0.002922
26 KINASE BINDING 13 606 9.281e-05 0.003316
27 CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS 4 42 0.0001273 0.004378
28 HEPARAN SULFATE PROTEOGLYCAN BINDING 3 18 0.0001731 0.005744
29 MOLECULAR FUNCTION REGULATOR 20 1353 0.000217 0.006951
30 TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING 4 50 0.0002521 0.007806
31 ENHANCER BINDING 5 93 0.0002736 0.008198
NumGOOverlapSizeP ValueAdj. P Value
1 EXTRACELLULAR MATRIX 16 426 8.002e-09 4.673e-06
2 PROTEINACEOUS EXTRACELLULAR MATRIX 14 356 4.16e-08 1.215e-05
3 LATERAL PLASMA MEMBRANE 6 50 6.095e-07 0.0001187
4 EXTRACELLULAR SPACE 25 1376 8.301e-07 0.0001212
5 BANDED COLLAGEN FIBRIL 3 12 4.796e-05 0.005601
6 BETA CATENIN DESTRUCTION COMPLEX 3 14 7.863e-05 0.007654

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04310_Wnt_signaling_pathway 14 151 5.055e-13 9.099e-11
2 hsa04390_Hippo_signaling_pathway 13 154 1.188e-11 1.07e-09
3 hsa04510_Focal_adhesion 12 200 3.917e-09 2.35e-07
4 hsa04340_Hedgehog_signaling_pathway 6 56 1.208e-06 5.438e-05
5 hsa04520_Adherens_junction 6 73 5.819e-06 0.0002095
6 hsa04512_ECM.receptor_interaction 6 85 1.408e-05 0.0004138
7 hsa04012_ErbB_signaling_pathway 6 87 1.609e-05 0.0004138
8 hsa04144_Endocytosis 8 203 3.727e-05 0.0008385
9 hsa04151_PI3K_AKT_signaling_pathway 10 351 6.323e-05 0.001265
10 hsa04664_Fc_epsilon_RI_signaling_pathway 5 79 0.000127 0.002287
11 hsa04914_Progesterone.mediated_oocyte_maturation 5 87 0.0002003 0.003277
12 hsa04010_MAPK_signaling_pathway 8 268 0.0002556 0.003833
13 hsa04916_Melanogenesis 5 101 0.000401 0.005552
14 hsa04370_VEGF_signaling_pathway 4 76 0.001242 0.01597
15 hsa04350_TGF.beta_signaling_pathway 4 85 0.001879 0.02254
16 hsa04014_Ras_signaling_pathway 6 236 0.003419 0.03847
17 hsa04660_T_cell_receptor_signaling_pathway 4 108 0.004463 0.04726
18 hsa04114_Oocyte_meiosis 4 114 0.005403 0.05403
19 hsa04621_NOD.like_receptor_signaling_pathway 3 59 0.005743 0.05441
20 hsa04062_Chemokine_signaling_pathway 5 189 0.006292 0.05663
21 hsa04722_Neurotrophin_signaling_pathway 4 127 0.007874 0.06039
22 hsa04110_Cell_cycle 4 128 0.008091 0.06039
23 hsa04380_Osteoclast_differentiation 4 128 0.008091 0.06039
24 hsa04360_Axon_guidance 4 130 0.008535 0.06039
25 hsa03430_Mismatch_repair 2 23 0.008723 0.06039
26 hsa04710_Circadian_rhythm_._mammal 2 23 0.008723 0.06039
27 hsa04530_Tight_junction 4 133 0.00923 0.06153
28 hsa04910_Insulin_signaling_pathway 4 138 0.01047 0.0673
29 hsa04662_B_cell_receptor_signaling_pathway 3 75 0.01111 0.06897
30 hsa04974_Protein_digestion_and_absorption 3 81 0.01367 0.08204
31 hsa04912_GnRH_signaling_pathway 3 101 0.02446 0.1411
32 hsa04620_Toll.like_receptor_signaling_pathway 3 102 0.02509 0.1411
33 hsa04670_Leukocyte_transendothelial_migration 3 117 0.03559 0.1941
34 hsa04810_Regulation_of_actin_cytoskeleton 4 214 0.04327 0.2291
35 hsa04623_Cytosolic_DNA.sensing_pathway 2 56 0.04658 0.2395
36 hsa04920_Adipocytokine_signaling_pathway 2 68 0.06573 0.3189
37 hsa04115_p53_signaling_pathway 2 69 0.06742 0.3189
38 hsa04730_Long.term_depression 2 70 0.06914 0.3189
39 hsa04622_RIG.I.like_receptor_signaling_pathway 2 71 0.07086 0.3189
40 hsa04020_Calcium_signaling_pathway 3 177 0.09591 0.4211
41 hsa04514_Cell_adhesion_molecules_.CAMs. 2 136 0.204 0.7811
42 hsa04650_Natural_killer_cell_mediated_cytotoxicity 2 136 0.204 0.7811
43 hsa04120_Ubiquitin_mediated_proteolysis 2 139 0.2107 0.7901
44 hsa04630_Jak.STAT_signaling_pathway 2 155 0.2469 0.8547

Quest ID: 6740d0a87a5cb50f30de471e4bd7526a